Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

YS Biopharma Co., Ltd. - Ordinary Shares (NQ: YS )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about YS Biopharma Co., Ltd. - Ordinary Shares

Shareholders of YS Biopharma Announce an Extraordinary General Meeting
Via GlobePRwire
NASDAQ: YS Investor Notice: Investigation over Potential Wrongdoing at YS Biopharma Co., Ltd.
San Diego, CA -- (SBWIRE) -- 06/19/2023 -- Certain directors of YS Biopharma Co., Ltd. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
YS INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIH
From The Rosen Law Firm PA
Via GlobeNewswire
YS INVESTOR ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
YS INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIH
From The Rosen Law Firm PA
Via GlobeNewswire
YS, SMIH LOSS ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NASDAQ: YS Investor Alert: Investigation over Possible Securities Laws Violations by YS Biopharma Co., Ltd.
San Diego, CA -- (SBWIRE) -- 05/09/2023 -- YS Biopharma Co., Ltd. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against YS Biopharma Co., Ltd. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against YS Biopharma Co., Ltd. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIH
From The Rosen Law Firm, P.A.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.